Biosimilars: development and investigation using achievements in modern biotechnology

Biosimilars are biological drug products that have an equivalent clinical profile with innovator biotherapeutics but are developed under a reduced program. To this end, specific comparability approaches are followed based on reverse engineering that involves a thorough analysis of the innovator biot...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: R. R. Niyazov, M. A. Dranitsyna, A. N. Vasiliev, E. V. Gavrishina
Format: article
Langue:EN
RU
Publié: Endocrinology Research Centre 2021
Sujets:
Accès en ligne:https://doaj.org/article/3890df950eda4cfaab3a564c6fd838b2
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires